Application of a multi-stacked fentanyl patch could result in serious, life-threatening, or fatal respiratory depression.

Transdermal patches are designed to provide an alternative route of administration for opioid or stimulant drugs that are prescribed for treatment of conditions such as chronic pain, opioid use ...

Nutriband's AVERSA™ abuse-deterrent technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential ...

Key Takeaways The Automatic Transdermal System Market is experiencing significant growth driven by the rising demand for non-invasive drug delivery methods. The Automatic Transdermal System Market ...

The first transdermal patch used to treat schizophrenia has been approved by the U.S. Food and Drug Administration. The medication, asenapine, manufactured by Hisamitsu Pharmaceutical, will be ...

The Belgian drug maker announced the launch of Neupro (rotigotine) transdermal system, which the Food and Drug Administration approved in April. The drug is a once-daily patch that provides ...

The first TDDS entered the U.S. market in 1979 with the approval of the scopolamine patch by the Food and Drug Administration (FDA) for treatment of motion sickness. [1, 2] Today there are more ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to Zygel™ (cannabidiol gel; Zynerba Pharmaceuticals) for the treatment of 22q11.2 deletion syndrome (22q), a ...

Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, Such as a Transdermal Patch NEW YORK, July 25, 2013 /PRNewswire/ -- Alliqua, Inc. (OTCQB: ALQA), a wound ...